Gastrointestinal Cancers: New Advances and Challenges
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Clinical Medicine, Cell, and Organism Physiology".
Deadline for manuscript submissions: 25 June 2025 | Viewed by 728
Special Issue Editor
Special Issue Information
Dear Colleagues,
We are pleased to announce that we will call for contributions for publication in JPM’s Special Issue, titled Gastrointestinal Cancers: New Advances and Challenges. Today, various guidelines for the treatment of gastrointestinal cancers based on large-scale clinical studies are being developed around the world, and many patients can benefit from standardized treatment. On the other hand, excessive indications of standardized treatment may impede optimal advanced medical care for individual patients. Gastrointestinal oncology is progressing day by day, and new disease concepts, new pathogenic mechanisms, and new diagnostic and therapeutic modalities are being developed one after another. This Special Issue seeks all types of contributions on diagnostic problems and solutions, the efficacy and limitations of standardized treatments, approaches to individualized treatments, novel and challenging diagnostic and therapeutic modalities, and their clinical experiences. It is important to share your knowledge and experience with our readers, and we therefore consider papers on negative data and unsuccessful cases, among other things.
Dr. Yasuo Imai
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gastrointestinal cancer
- guideline
- disease concept
- mechanism of disease
- diagnosis
- endoscopy
- surgery
- chemotherapy
- molecular targeted therapy
- immunotherapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
